ATB 107
an indole-3-glycerol phosphate synthase inhibitor with antibacterial activity; structure in first source
Also Known As:
ATB-107; ATB107
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Huang, Qiang:
2 articles
(06/2010 - 01/2009)
|
2. | Shen, Hongbo:
2 articles
(06/2010 - 01/2009)
|
3. | Wang, Feifei:
2 articles
(06/2010 - 01/2009)
|
4. | Wang, Honghai:
2 articles
(06/2010 - 01/2009)
|
5. | Xu, Shengfeng:
2 articles
(06/2010 - 01/2009)
|
6. | Campanerut-Sá, Paula Aline Zanetti:
1 article
(12/2017)
|
7. | Cardoso, Rosilene Fressatti:
1 article
(12/2017)
|
8. | Ghiraldi-Lopes, Luciana Dias:
1 article
(12/2017)
|
9. | Meneguello, Jean Eduardo:
1 article
(12/2017)
|
10. | Pavan, Fernando Rogério:
1 article
(12/2017)
|
Related Diseases
1. | Tuberculosis (Tuberculoses)
06/01/2010
- " tuberculosis since the altered expression in response to ATB107 of some genes, such as Rv3140, Rv2243, and Rv2428, is consistent with INH or ethionamide treatment. " 06/01/2010
- " tuberculosis, two-dimensional gel electrophoresis coupled with MALDI-TOF-MS analysis (2-DE-MS) was performed to illustrate alterations in the protein expression profile in response to ATB107. " 12/01/2017
- " tuberculosis after exposure to isoniazid, ethambutol, streptomycin, ofloxacin, moxifloxacin and two new drugs candidates, SQ109 and ATB107. "
|
2. | Leukemia
|
|
Related Drugs and Biologics